Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,888	1,829	1,318	1,260	985	1,154
Market Cap Growth	-8.10%	38.81%	4.57%	27.92%	-14.60%	-25.58%
Enterprise Value	2,373	2,240	1,629	1,521	1,202	1,377
Last Close Price	786.60	761.13	547.29	522.40	408.39	476.46
PE Ratio	187.31	188.91	144.98	156.37	-	317.23
PS Ratio	8.03	8.34	6.65	6.96	9.95	4.04
PB Ratio	58.57	62.17	56.46	23.92	21.97	19.94
P/TBV Ratio	58.57	62.17	56.46	23.92	21.97	19.94
EV/Sales Ratio	10.09	10.22	8.22	8.40	12.14	4.83
EV/EBITDA Ratio	107.32	122.73	80.79	77.41	-	75.98
EV/EBIT Ratio	181.23	180.50	123.64	102.35	-	119.74
EV/FCF Ratio	-31.91	-	-	-	-	-
Debt / Equity Ratio	19.37	16.23	16.82	6.55	5.35	3.94
Debt / EBITDA Ratio	28.23	25.86	18.95	16.49	-	11.72
Asset Turnover	0.36	0.40	0.39	0.39	0.23	0.69
Inventory Turnover	0.51	0.49	0.49	0.54	0.40	0.88
Quick Ratio	0.50	0.38	0.34	0.29	0.29	0.22
Current Ratio	0.91	0.91	0.88	0.92	0.87	0.89
Return on Equity (ROE)	35.50%	36.70%	23.91%	16.53%	-25.34%	6.29%
Return on Assets (ROA)	1.27%	1.41%	1.62%	2.01%	-1.07%	1.73%
Return on Capital (ROIC)	1.45%	1.68%	2.02%	2.72%	-1.60%	2.55%
Return on Capital Employed (ROCE)	36.40%	36.30%	44.70%	24.80%	-	17.00%
Earnings Yield	0.53%	0.53%	0.69%	0.64%	-1.32%	0.32%
FCF Yield	-3.94%	-3.72%	-2.68%	-5.93%	-0.55%	-1.10%
Dividend Yield	0.13%	0.13%	0.27%	0.19%	-	0.32%
Payout Ratio	23.81%	34.91%	11.00%	18.61%	-	81.16%
Total Shareholder Return	0.13%	0.13%	0.27%	0.19%	-	0.32%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.